Cel-Sci Corporation Stock Prediction
AI-powered sentiment analysis and prediction trends for CVM, updated each market day.
CVM AI Sentiment
AI sees no strong directional signal for Cel-Sci Corporation stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Cel-Sci Corporation
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
Sector
Exchange
Market Cap
$36,200,098
Cap Tier
Employees
44
Headquarters
VIENNA, VA
Listed Since
Dec. 8, 1983
Website
CVM Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CVM Volatility
Cel-Sci Corporation has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
